Gilead Sciences Inc (WBO:GILD)
€ 82.34 -0.83 (-1%) Market Cap: 103.30 Bil Enterprise Value: 122.22 Bil PE Ratio: 109.56 PB Ratio: 6.12 GF Score: 77/100

Q4 2023 Gilead Sciences Inc Earnings Call Transcript

Feb 06, 2024 / 10:00PM GMT
Release Date Price: €72.38 (+1.09%)
Operator

Good afternoon. Thank you for attending the Fourth Quarter and Full Year 2023 Gilead Sciences Earnings Conference Call. My name is Victoria, and I'll be your moderator today.

(Operator Instructions) I would now like to pass the conference over to your host, Jacquie Ross. Thank you. You may proceed, Jacquie.

Jacquie Ross
Gilead Sciences, Inc. - VP of IR

Thank you, operator, and good afternoon, everyone.

Just after market close today, we issued a press release with earnings results for the fourth quarter and full year of 2023. The press release, slides and supplementary data are available on the Investors section of our website at gilead.com.

The speakers on today's call will be our Chairman and Chief Executive Officer, Daniel O'Day; our Chief Commercial Officer; Johanna Mercier, our Chief Medical Officer, Merdad Parsey; and our Chief Financial Officer, Andrew Dickinson. After that, we'll open the call to Q&A where the team will be joined by Cindy Perettie, the Executive Vice President of Kite.

Before we get started,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot